Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Sassier

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|January 26, 2019
Fluoroquinolone and Aortic Dissection: Is It a Class Effect?Charles Dolladille, Basile Chrétien, Marion Sassier, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners]Xavier Humbert, Basile Chrétien, Marion Sassier, et al.
Drug Safety - Case Reports|October 18, 2016
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.
European Journal of Clinical Pharmacology|May 22, 2020
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databasesBasile Chrétien, Marion Sassier, Joachim Alexandre, et al.
Drug Safety - Case Reports|March 31, 2017
Hazardous Drug Diversion of Valproate from a General Practitioner to his Patient's DogPierre-Marie Morice, Joachim Alexandre, Alexandre Cesbron, et al.
Human Psychopharmacology|November 18, 2020
Could N-acetylcysteine improve the safety of clozapine?Basile Chrétien, Sophie Fedrizzi, Véronique Lelong-Boulouard, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|April 5, 2023
General medicine and notification of adverse reactions: contributions of health insurance representativesSophie Fedrizzi, Basile Chrétien, Marion Sassier, et al.
Case Reports in Oncology|November 20, 2014
Two cases of fatal encephalopathy related to Ifosfamide: an adverse role of aprepitant?Alice Séjourné, Sabine Noal, Mathieu Boone, et al.
European Journal of Clinical Pharmacology|August 25, 2015
Rivaroxaban-induced hair lossBasile Chrétien, Anne Besnard, Marion Sassier, et al.
Pediatric Blood & Cancer|May 18, 2026
Age-Dependent Cardiovascular Adverse Event Reporting With Pathway-Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality AnalysisFabien Labombarda, Damien Bodet, Jérémie Rouger, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|January 26, 2019
Fluoroquinolone and Aortic Dissection: Is It a Class Effect?Charles Dolladille, Basile Chrétien, Marion Sassier, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners]Xavier Humbert, Basile Chrétien, Marion Sassier, et al.
Drug Safety - Case Reports|October 18, 2016
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.
European Journal of Clinical Pharmacology|May 22, 2020
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databasesBasile Chrétien, Marion Sassier, Joachim Alexandre, et al.
Drug Safety - Case Reports|March 31, 2017
Hazardous Drug Diversion of Valproate from a General Practitioner to his Patient's DogPierre-Marie Morice, Joachim Alexandre, Alexandre Cesbron, et al.
Human Psychopharmacology|November 18, 2020
Could N-acetylcysteine improve the safety of clozapine?Basile Chrétien, Sophie Fedrizzi, Véronique Lelong-Boulouard, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|April 5, 2023
General medicine and notification of adverse reactions: contributions of health insurance representativesSophie Fedrizzi, Basile Chrétien, Marion Sassier, et al.
Case Reports in Oncology|November 20, 2014
Two cases of fatal encephalopathy related to Ifosfamide: an adverse role of aprepitant?Alice Séjourné, Sabine Noal, Mathieu Boone, et al.
European Journal of Clinical Pharmacology|August 25, 2015
Rivaroxaban-induced hair lossBasile Chrétien, Anne Besnard, Marion Sassier, et al.
Pediatric Blood & Cancer|May 18, 2026
Age-Dependent Cardiovascular Adverse Event Reporting With Pathway-Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality AnalysisFabien Labombarda, Damien Bodet, Jérémie Rouger, et al.
Pageof 5